Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis

• The present study assessed the association between the use of metformin and cancer risk in T2DM patients. • 67 studies met the inclusion criteria for this study, with 10,695,875 T2DM patients and 145,108 cancer cases. • Our meta-analysis indicated that metformin may be a independent protective fac...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser: Zhang, Kui (VerfasserIn)
Weitere Verfasser: Bai, Peng (BerichterstatterIn), Dai, Hao (BerichterstatterIn), Deng, Zhenhua (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:Type 2 diabetes (T2DM) Metformin Cancer Meta-analysis
Umfang:7
LEADER 01000caa a22002652 4500
001 ELV052596737
003 DE-627
005 20230624184845.0
007 cr uuu---uuuuu
008 210910s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.pcd.2020.06.001  |2 doi 
028 5 2 |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001249.pica 
035 |a (DE-627)ELV052596737 
035 |a (ELSEVIER)S1751-9918(20)30213-8 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 4 |a 630  |q VZ 
082 0 4 |a 640  |q VZ 
082 0 4 |a 590  |q VZ 
082 0 4 |a 610  |q VZ 
082 0 4 |a 600  |q VZ 
084 |a 50.70  |2 bkl 
100 1 |a Zhang, Kui  |e verfasserin  |4 aut 
245 1 0 |a Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis 
264 1 |c 2021 
300 |a 7 
336 |a nicht spezifiziert  |b zzz  |2 rdacontent 
337 |a nicht spezifiziert  |b z  |2 rdamedia 
338 |a nicht spezifiziert  |b zu  |2 rdacarrier 
520 |a • The present study assessed the association between the use of metformin and cancer risk in T2DM patients. • 67 studies met the inclusion criteria for this study, with 10,695,875 T2DM patients and 145,108 cancer cases. • Our meta-analysis indicated that metformin may be a independent protective factor for cancer risk in T2DM patients. 
650 7 |a Type 2 diabetes (T2DM)  |2 Elsevier 
650 7 |a Metformin  |2 Elsevier 
650 7 |a Cancer  |2 Elsevier 
650 7 |a Meta-analysis  |2 Elsevier 
700 1 |a Bai, Peng  |4 oth 
700 1 |a Dai, Hao  |4 oth 
700 1 |a Deng, Zhenhua  |4 oth 
773 0 8 |i Enthalten in  |n Elsevier  |a David, Lauren A. ELSEVIER  |t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients  |d 2016  |g Amsterdam [u.a.]  |w (DE-627)ELV024210129 
773 1 8 |g volume:15  |g year:2021  |g number:1  |g pages:52-58  |g extent:7 
856 4 0 |u https://doi.org/10.1016/j.pcd.2020.06.001  |3 Volltext 
912 |a GBV_USEFLAG_U 
912 |a GBV_ELV 
912 |a SYSFLAG_U 
912 |a GBV_ILN_24 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
936 b k |a 50.70  |j Energie: Allgemeines  |q VZ 
951 |a AR 
952 |d 15  |j 2021  |e 1  |h 52-58  |g 7